These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18337140)

  • 1. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.
    Manosuthi W; Prasithsirikul W; Chumpathat N; Suntisuklappon B; Athichathanabadi C; Chimsuntorn S; Sungkanuparph S
    Int J Infect Dis; 2008 Nov; 12(6):582-6. PubMed ID: 18337140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?
    Imhof A; Ledergerber B; Günthard HF; Haupts S; Weber R;
    Clin Infect Dis; 2005 Sep; 41(5):721-8. PubMed ID: 16080096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
    Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
    Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.
    Noguera A; Fortuny C; Sanchez E; Artuch R; Vilaseca MA; Muñoz-Almagro C; Pou J; Jiménez R
    Pediatr Infect Dis J; 2003 Sep; 22(9):778-82. PubMed ID: 14506367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
    Osler M; Stead D; Rebe K; Meintjes G; Boulle A
    HIV Med; 2010 Feb; 11(2):121-9. PubMed ID: 19702629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
    Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
    Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
    Dragovic G; Jevtovic D
    Biomed Pharmacother; 2012 Jun; 66(4):308-11. PubMed ID: 22658063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa.
    Stead D; Osler M; Boulle A; Rebe K; Meintjes G
    Antivir Ther; 2008; 13(7):937-43. PubMed ID: 19043928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line therapy and mitochondrial damage: different nucleosides, different findings.
    Blanco F; García-Benayas T; José de la Cruz J; González-Lahoz J; Soriano V
    HIV Clin Trials; 2003; 4(1):11-9. PubMed ID: 12577192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acidosis associated with stavudine administration: a report of five cases.
    Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
    Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
    Antoniou T; Weisdorf T; Gough K
    CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
    Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
    Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of antiretroviral therapy in HIV-1 infected children.
    Shah I
    J Trop Pediatr; 2006 Aug; 52(4):244-8. PubMed ID: 16126803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
    Guo JJ; Jang R; Louder A; Cluxton RJ
    Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.